We help communities to created a custom knowledge base(still being refined)
Click here to view original web page at www.globenewswire.com
PITTSBURGH, Oct. 15, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced its sponsorship of the Fourth International Symposium on Sigma-2 Receptors: Role in Health and Disease. […]
Click here to view original web page at www.globenewswire.com
PITTSBURGH, Oct. 15, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced its sponsorship of the Fourth International Symposium on Sigma-2 Receptors: Role in Health and Disease. […]
Click here to view original web page at www.eurekalert.org
IMAGE: Depletion of Caveolin-1 in Type-2 Diabetes Model Induces Alzheimer’s disease Pathology Precursors view more Researchers have identified a protein that may contribute to the progression of Alzheimer’s disease pathology in type-2 diabetes, reports a new study of male mice and human brain tissue. The research could have implications […]
Click here to view original web page at www.globenewswire.com
NEW HAVEN, Conn., Oct. 14, 2019 (GLOBE NEWSWIRE) — RxGen, a preclinical translational research company, will be presenting a poster highlighting its progress in advancing preclinical models of Alzheimer’s disease (AD) to better predict clinical outcomes during the Society for Neuroscience (SfN) 49 th Annual Meeting in Chicago from […]
Click here to view original web page at www.miningjournal.net
MARQUETTE — Recent developments in the diagnosis and treatment of Alzheimer’s disease will be the topic of the next Your Health presentation at Northern Michigan University. Scott Counts, associate professor of translational neuroscience at Michigan State University, will give the talk at 7 p.m. Thursday in Reynolds Recital Hall. […]
Click here to view original web page at www.alzforum.org
As if the known universe of RNAs wasn’t vast enough, here’s a new entity: circular RNA. These rings form when the ends of a linear transcript become fastened together. Are they a result of splicing gone haywire, or do they serve a purpose? The latter, according to evidence published […]
Click here to view original web page at www.bcm.edu
A sculpture of a cross-section of the human brain. Dr. Joshua Shulman, associate professor of neurology, neuroscience and molecular and human genetics at Baylor College of Medicine and investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital. A collaborative study published today in the […]
Click here to view original web page at www.financialbuzz.com
Pittsburgh, Oct. 10, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced that the Company would be presenting three posters on Elayta™ (CT1812), Cognition’s lead experimental medicine, […]
Click here to view original web page at finance.yahoo.com
WILMINGTON, Mass.–(BUSINESS WIRE)– Charles River Laboratories International, Inc. ( CRL ) announced today that the Company has been selected by Alzheimer’s Research UK to join the Dementia Consortium. The Consortium is a global charity-industry partnership aimed at funding promising research from academia and helping progress projects with the scale […]
Click here to view original web page at www.technologynetworks.com
Credit: The Picower Institute for Learning and Memory Long before symptoms like memory loss even emerge, the underlying pathology of Alzheimer’s disease, such as an accumulation of amyloid protein plaques, is well underway in the brain. A longtime goal of the field has been to understand where it starts […]
